Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
Authors
Keywords
-
Journal
DRUGS
Volume 79, Issue 10, Pages 1103-1134
Publisher
Springer Science and Business Media LLC
Online
2019-06-17
DOI
10.1007/s40265-019-01147-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological Products: Cellular Therapy and FDA Approved Products
- (2019) Ali Golchin et al. Stem Cell Reviews and Reports
- Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future
- (2019) Madeleine Taylor et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Effect of enzyme replacement therapy on the growth of patients with Morquio A
- (2019) Caitlin Doherty et al. JOURNAL OF HUMAN GENETICS
- Children with mucopolysaccharidosis risk progressive visual dysfunction despite haematopoietic stem cell transplants
- (2018) Kristina Teär Fahnehjelm et al. ACTA PAEDIATRICA
- Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I
- (2018) William M. Pardridge et al. BIODRUGS
- Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris
- (2018) Natalia Pimentel et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Busulfan, Fludarabine, and Cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis
- (2018) Yao Chen et al. BONE MARROW TRANSPLANTATION
- Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers
- (2018) Roselena Silvestri Schuh et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- The efficacy of intracerebroventricular idursulfase-beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology
- (2018) Young Bae Sohn et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Pulmonary Function Tests for the Generalist: A Brief Review
- (2018) Timothy M. Dempsey et al. MAYO CLINIC PROCEEDINGS
- Anti-drug antibody response in mucopolysaccharidosis type I patients treated with AGT-181, a brain penetrating human insulin receptor antibody-iduronidase fusion protein
- (2018) Mathias Schmidt et al. MOLECULAR GENETICS AND METABOLISM
- Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis
- (2018) Shaukat A. Khan et al. MOLECULAR GENETICS AND METABOLISM
- Chaperone effect of sulfated disaccharide from heparin on mutant iduronate-2-sulfatase in mucopolysaccharidosis type II
- (2018) Hiroo Hoshina et al. MOLECULAR GENETICS AND METABOLISM
- A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
- (2018) Hiroyuki Sonoda et al. MOLECULAR THERAPY
- Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
- (2018) Kanut Laoharawee et al. MOLECULAR THERAPY
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer
- (2018) Manmeet S. Ahluwalia et al. ONCOLOGIST
- Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan
- (2018) Chih-Kuang Chuang et al. Orphanet Journal of Rare Diseases
- Tuning protein folding in lysosomal storage diseases: the chemistry behind pharmacological chaperones
- (2018) David M. Pereira et al. Chemical Science
- A novel LC–MS/MS assay to quantify dermatan sulfate in cerebrospinal fluid as a biomarker for mucopolysaccharidosis II
- (2018) Peng Pan et al. Bioanalysis
- Intrathecal/Intracerebroventricular enzyme replacement therapy for the mucopolysaccharidoses: efficacy, safety, and prospects
- (2018) Roberto Giugliani et al. Expert Opinion on Orphan Drugs
- In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
- (2018) Roselena Silvestri Schuh et al. JOURNAL OF CONTROLLED RELEASE
- Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS
- (2018) Noboru Tanaka et al. MOLECULAR GENETICS AND METABOLISM
- Haematopoietic stem cell transplantation for mucopolysaccharidosis type VII: A case report
- (2018) Luisa Sisinni et al. PEDIATRIC TRANSPLANTATION
- The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses
- (2018) Hsiang-Yu Lin et al. Molecular Genetics & Genomic Medicine
- Pharmacokinetic and Pharmacodynamic Modeling to Optimize the Dose of Vestronidase Alfa, an Enzyme Replacement Therapy for Treatment of Patients with Mucopolysaccharidosis Type VII: Results from Three Trials
- (2018) Yulan Qi et al. CLINICAL PHARMACOKINETICS
- Recent trends in mucopolysaccharidosis research
- (2018) Hiroshi Kobayashi JOURNAL OF HUMAN GENETICS
- Iduronate-2-Sulfatase with Anti-human Transferrin Receptor Antibody for Neuropathic Mucopolysaccharidosis II: A Phase 1/2 Trial
- (2018) Torayuki Okuyama et al. MOLECULAR THERAPY
- ZFN-Mediated In Vivo Genome Editing Corrects Murine Hurler Syndrome
- (2018) Li Ou et al. MOLECULAR THERAPY
- Sangamo's landmark genome editing trial gets mixed reception
- (2018) Cormac Sheridan NATURE BIOTECHNOLOGY
- Tailoring the AAV2 capsid vector for bone-targeting
- (2018) Carlos J. Alméciga-Díaz et al. PEDIATRIC RESEARCH
- Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience
- (2017) Nathan J. Rodgers et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation
- (2017) Su Han Lum et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Enzyme replacement therapy and beyond—in memoriam Roscoe O. Brady, M.D. (1923–2016)
- (2017) Markus Ries JOURNAL OF INHERITED METABOLIC DISEASE
- Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management
- (2017) Lorne A. Clarke et al. JOURNAL OF PEDIATRICS
- Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial
- (2017) Marc Tardieu et al. LANCET NEUROLOGY
- How close are we to therapies for Sanfilippo disease?
- (2017) Lidia Gaffke et al. METABOLIC BRAIN DISEASE
- Correlation between urinary GAG and anti-idursulfase ERT neutralizing antibodies during treatment with NICIT immune tolerance regimen: A case report
- (2017) Sarah Kim et al. MOLECULAR GENETICS AND METABOLISM
- Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody–Iduronidase Fusion Protein
- (2017) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Minimal clinically important difference for the 6-min walk test: literature review and application to Morquio A syndrome
- (2017) Rudolf Schrover et al. Orphanet Journal of Rare Diseases
- Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease
- (2017) Yu-Hone Hsu et al. Orphanet Journal of Rare Diseases
- Early disease progression of Hurler syndrome
- (2017) Bridget T. Kiely et al. Orphanet Journal of Rare Diseases
- Open issues in Mucopolysaccharidosis type I-Hurler
- (2017) Rossella Parini et al. Orphanet Journal of Rare Diseases
- N-glycan structures and downstream mannose-phosphorylation of plant recombinant human alpha-l-iduronidase: toward development of enzyme replacement therapy for mucopolysaccharidosis I
- (2017) Owen M. Pierce et al. PLANT MOLECULAR BIOLOGY
- Reference Equations for the Six-Minute Walk Distance in the Healthy Chinese Han Population, Aged 18–30 Years
- (2017) He Zou et al. BMC Pulmonary Medicine
- Mucopolysaccharidosis type III: current clinical trials, challenges and recommendations
- (2017) Stephanie CM Nijmeijer et al. Expert Opinion on Orphan Drugs
- Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice
- (2017) Mika Aoyagi-Scharber et al. Molecular Therapy-Methods & Clinical Development
- Improvement in the production of the human recombinant enzyme N-acetylgalactosamine-6-sulfatase (rhGALNS) in Escherichia coli using synthetic biology approaches
- (2017) Luis H. Reyes et al. Scientific Reports
- Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia
- (2016) Jun Aoki et al. AMERICAN JOURNAL OF HEMATOLOGY
- Allogeneic Hematopoietic Stem Cell Transplantation in Thirty-Four Pediatric Cases of Mucopolysaccharidosis—A Ten-Year Report from the China Children Transplant Group
- (2016) Jianmin Wang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue
- (2016) S E Ghazikhanian et al. BONE MARROW TRANSPLANTATION
- Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder
- (2016) Barbara King et al. EXPERIMENTAL NEUROLOGY
- A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome
- (2016) Leanne K. Winner et al. HUMAN GENE THERAPY
- Comparative study of idursulfase beta and idursulfase in vitro and in vivo
- (2016) Chihwa Kim et al. JOURNAL OF HUMAN GENETICS
- Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA
- (2016) Barbara King et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study
- (2016) Julia B. Hennermann et al. JOURNAL OF INHERITED METABOLIC DISEASE
- A Desensitization Method to Maintain Enzyme Replacement Therapy in Mucopolysaccharidosis Type VI
- (2016) D Kör et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Clinical course of sly syndrome (mucopolysaccharidosis type VII)
- (2016) Adriana M Montaño et al. JOURNAL OF MEDICAL GENETICS
- Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
- (2016) Derralynn A Hughes et al. JOURNAL OF MEDICAL GENETICS
- Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10year combined experience of 2 centres
- (2016) Arunabha Ghosh et al. MOLECULAR GENETICS AND METABOLISM
- Hematopoietic stem cell transplantation for Morquio A syndrome
- (2016) Hiromasa Yabe et al. MOLECULAR GENETICS AND METABOLISM
- Safety study of sodium pentosan polysulfate for adult patients with mucopolysaccharidosis type II
- (2016) Kenji Orii et al. MOLECULAR GENETICS AND METABOLISM
- Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome
- (2016) Christian J. Hendriksz et al. MOLECULAR GENETICS AND METABOLISM
- Elevated TNF-α is associated with pain and physical disability in mucopolysaccharidosis types I, II, and VI
- (2016) Lynda E. Polgreen et al. MOLECULAR GENETICS AND METABOLISM
- Effect of anti-laronidase antibodies on efficacy and safety of laronidase enzyme replacement therapy for MPS I: A comprehensive meta-analysis of pooled data from multiple studies
- (2016) Yong Xue et al. MOLECULAR GENETICS AND METABOLISM
- A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA
- (2016) Simon A. Jones et al. MOLECULAR GENETICS AND METABOLISM
- Insulin Receptor Antibody−α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood–Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts
- (2016) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- A Comprehensive Map of CNS Transduction by Eight Recombinant Adeno-associated Virus Serotypes Upon Cerebrospinal Fluid Administration in Pigs
- (2016) Nicolina Cristina Sorrentino et al. MOLECULAR THERAPY
- Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII
- (2016) Brittney L Gurda et al. MOLECULAR THERAPY
- Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series
- (2016) Dafne Dain Gandelman Horovitz et al. Orphanet Journal of Rare Diseases
- Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation
- (2016) Mona Schmidt et al. Orphanet Journal of Rare Diseases
- A novel LC–MS/MS assay for heparan sulfate screening in the cerebrospinal fluid of mucopolysaccharidosis IIIA patients
- (2016) Hicham Naimy et al. Bioanalysis
- Crossing the blood–brain-barrier with viral vectors
- (2016) Haiyan Fu et al. Current Opinion in Virology
- Hematopoietic stem cell transplant for the mucopolysaccharidoses
- (2016) S.H. Lum et al. Expert Opinion on Orphan Drugs
- Reference value for the 6-minute walk test in children and adolescents: a systematic review
- (2016) C. F. Mylius et al. Expert Review of Respiratory Medicine
- Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris
- (2016) Alexander Rodríguez-López et al. Scientific Reports
- Elevated cerebral spinal fluid biomarkers in children with mucopolysaccharidosis I-H
- (2016) Gerald V. Raymond et al. Scientific Reports
- Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot study
- (2015) Barbara K. Burton et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Analysis of Total Human Urinary Glycosaminoglycan Disaccharides by Liquid Chromatography–Tandem Mass Spectrometry
- (2015) Xiaojun Sun et al. ANALYTICAL CHEMISTRY
- Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy
- (2015) Bruna Donida et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Hematopoietic Cell Transplantation for Mucopolysaccharidosis Patients Is Safe and Effective: Results after Implementation of International Guidelines
- (2015) Mieke Aldenhoven et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- In vivo genome editing of the albumin locus as a platform for protein replacement therapy
- (2015) R. Sharma et al. BLOOD
- Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial
- (2015) Becky Schweighardt et al. CLINICAL THERAPEUTICS
- A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II
- (2015) Joseph Muenzer et al. GENETICS IN MEDICINE
- Hematopoietic Stem Cell Gene Therapy Corrects Neuropathic Phenotype in Murine Model of Mucopolysaccharidosis Type II
- (2015) Taichi Wakabayashi et al. HUMAN GENE THERAPY
- First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient
- (2015) Joyce E. Fox et al. MOLECULAR GENETICS AND METABOLISM
- Multi-domain impact of elosulfase alfa in Morquio A syndrome in the pivotal phase III trial
- (2015) Christian J. Hendriksz et al. MOLECULAR GENETICS AND METABOLISM
- Human recombinant lysosomal enzymes produced in microorganisms
- (2015) Ángela J. Espejo-Mojica et al. MOLECULAR GENETICS AND METABOLISM
- Safety of laronidase delivered into the spinal canal for treatment of cervical stenosis in mucopolysaccharidosis I
- (2015) Patricia I. Dickson et al. MOLECULAR GENETICS AND METABOLISM
- Safety and efficacy of enzyme replacement therapy with idursulfase beta in children aged younger than 6years with Hunter syndrome
- (2015) Young Bae Sohn et al. MOLECULAR GENETICS AND METABOLISM
- Therapies for the bone in mucopolysaccharidoses
- (2015) Shunji Tomatsu et al. MOLECULAR GENETICS AND METABOLISM
- Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
- (2015) Giancarlo Parenti et al. MOLECULAR THERAPY
- Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome
- (2015) Shunji Tomatsu et al. Drug Design Development and Therapy
- Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations
- (2015) Shunji Tomatsu et al. Expert Opinion on Orphan Drugs
- Elosulfase alfa: First Global Approval
- (2014) Mark Sanford et al. DRUGS
- Pharmacological chaperone therapy for lysosomal storage diseases
- (2014) Giancarlo Parenti et al. Future Medicinal Chemistry
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy
- (2014) Albert Ribera et al. HUMAN MOLECULAR GENETICS
- Current and potential therapeutic strategies for mucopolysaccharidoses
- (2014) H. Noh et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study
- (2014) Christian J. Hendriksz et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Long-term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case series
- (2014) Christina Lampe et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Computational analysis of human N-acetylgalactosamine-6-sulfate sulfatase enzyme: an update in genotype–phenotype correlation for Morquio A
- (2014) Sergio Olarte-Avellaneda et al. MOLECULAR BIOLOGY REPORTS
- Insulin Receptor Antibody–Sulfamidase Fusion Protein Penetrates the Primate Blood–Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type A Cells
- (2014) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Intrathecal Gene Therapy Corrects CNS Pathology in a Feline Model of Mucopolysaccharidosis I
- (2014) Christian Hinderer et al. MOLECULAR THERAPY
- Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
- (2014) Amit C. Nathwani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler Syndrome
- (2014) M. Dai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
- (2014) S.-h. Kan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin-like growth factor II peptide fusion enables uptake and lysosomal delivery of α-N-acetylglucosaminidase to mucopolysaccharidosis type IIIB fibroblasts
- (2013) Shih-hsin Kan et al. BIOCHEMICAL JOURNAL
- Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
- (2013) S J Gray et al. GENE THERAPY
- Strong Cortical and Spinal Cord Transduction After AAV7 and AAV9 Delivery into the Cerebrospinal Fluid of Nonhuman Primates
- (2013) Lluis Samaranch et al. HUMAN GENE THERAPY
- Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
- (2013) Virginia Haurigot et al. JOURNAL OF CLINICAL INVESTIGATION
- Pharmacological Chaperones as Therapeutics for Lysosomal Storage Diseases
- (2013) Robert E. Boyd et al. JOURNAL OF MEDICINAL CHEMISTRY
- Low-Scale expression and purification of an active putative iduronate 2-sulfate sulfatase-Like enzyme from Escherichia coli K12
- (2013) Edwin David Morales-Álvarez et al. JOURNAL OF MICROBIOLOGY
- A multi-national, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of BMN 110 treatment for mucopolysaccharidosis IVA (Morquio syndrome type A)
- (2013) Christian Hendriksz et al. MOLECULAR GENETICS AND METABOLISM
- Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease
- (2013) Ana Sergijenko et al. MOLECULAR THERAPY
- Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery
- (2013) LG Chicoine et al. MOLECULAR THERAPY
- A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
- (2013) Shuan-Pei Lin et al. Orphanet Journal of Rare Diseases
- Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
- (2013) F. Mingozzi et al. Science Translational Medicine
- Reference values for the 6-minute walk test in healthy children and adolescents in Switzerland
- (2013) Silvia Ulrich et al. BMC Pulmonary Medicine
- Enzyme Replacement Therapy for Lysosomal Diseases: Lessons from 20 Years of Experience and Remaining Challenges
- (2012) R.J. Desnick et al. Annual Review of Genomics and Human Genetics
- Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy
- (2012) M. A. Saif et al. HAEMATOLOGICA
- Correction of Pathological Accumulation of Glycosaminoglycans in Central Nervous System and Peripheral Tissues of MPSIIIA Mice Through Systemic AAV9 Gene Transfer
- (2012) Albert Ruzo et al. HUMAN GENE THERAPY
- Gene Therapy for Mucopolysaccharidosis Type VI Is Effective in Cats Without Pre-Existing Immunity to AAV8
- (2012) Rita Ferla et al. HUMAN GENE THERAPY
- Biomarkers for the mucopolysaccharidoses: Discovery and clinical utility
- (2012) Lorne A. Clarke et al. MOLECULAR GENETICS AND METABOLISM
- Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: A nationwide survey in Japan
- (2012) Akemi Tanaka et al. MOLECULAR GENETICS AND METABOLISM
- Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice
- (2012) Alexander Langford-Smith et al. MOLECULAR THERAPY
- The Six-Minute Walk Test in Chronic Pediatric Conditions: A Systematic Review of Measurement Properties
- (2012) B. Bartels et al. PHYSICAL THERAPY
- Characterization of a recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in E. coli for enzyme replacement therapy of Morquio A disease
- (2012) Angela Mosquera et al. PROCESS BIOCHEMISTRY
- Identification and Characterization of Pharmacological Chaperones to Correct Enzyme Deficiencies in Lysosomal Storage Disorders
- (2011) Kenneth J. Valenzano et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Analysis of Glycosaminoglycans in Cerebrospinal Fluid from Patients with Mucopolysaccharidoses by Isotope-Dilution Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry
- (2011) H. Zhang et al. CLINICAL CHEMISTRY
- Substrate Reduction Therapies for Mucopolysaccharidoses
- (2011) Joanna Jakobkiewicz-Banecka et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Genistein supplementation in patients affected by Sanfilippo disease
- (2011) Verónica Delgadillo et al. JOURNAL OF INHERITED METABOLIC DISEASE
- A 10 Patient Case Report on the Impact of Plasmapheresis Upon Neutralizing Factors Against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8
- (2011) Virginie Monteilhet et al. MOLECULAR THERAPY
- Several rAAV Vectors Efficiently Cross the Blood–brain Barrier and Transduce Neurons and Astrocytes in the Neonatal Mouse Central Nervous System
- (2011) Hongwei Zhang et al. MOLECULAR THERAPY
- Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery
- (2011) Haiyan Fu et al. MOLECULAR THERAPY
- Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
- (2011) Marlies J Valstar et al. Orphanet Journal of Rare Diseases
- Enzyme Replacement Therapy and/or Hematopoietic Stem Cell Transplantation at diagnosis in patients with Mucopolysaccharidosis type I: results of a European consensus procedure
- (2011) Minke H de Ru et al. Orphanet Journal of Rare Diseases
- Therapy for the mucopolysaccharidoses
- (2011) V. Valayannopoulos et al. RHEUMATOLOGY
- Orthopaedic aspects of mucopolysaccharidoses
- (2011) K. K. White RHEUMATOLOGY
- Measures of physical performance assessments: Self-Paced Walk Test (SPWT), Stair Climb Test (SCT), Six-Minute Walk Test (6MWT), Chair Stand Test (CST), Timed Up & Go (TUG), Sock Test, Lift and Carry Test (LCT), and Car Task
- (2011) Kim Bennell et al. ARTHRITIS CARE & RESEARCH
- Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model
- (2010) I. Visigalli et al. BLOOD
- Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome
- (2010) Joseph Muenzer et al. GENETICS IN MEDICINE
- Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
- (2010) Sylvie Boutin et al. HUMAN GENE THERAPY
- Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21
- (2010) Alexander Rodríguez et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI
- (2010) Sean Turbeville et al. MOLECULAR GENETICS AND METABOLISM
- Enhancement of Drug Delivery: Enzyme-replacement Therapy for Murine Morquio A Syndrome
- (2010) Shunji Tomatsu et al. MOLECULAR THERAPY
- Safe, Efficient, and Reproducible Gene Therapy of the Brain in the Dog Models of Sanfilippo and Hurler Syndromes
- (2010) N Matthew Ellinwood et al. MOLECULAR THERAPY
- Genistein Improves Neuropathology and Corrects Behaviour in a Mouse Model of Neurodegenerative Metabolic Disease
- (2010) Marcelina Malinowska et al. PLoS One
- Course of Cognitive Decline in Hematopoietic Stem Cell Transplantation: A Within-subjects Design
- (2009) M. A. Friedman et al. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
- Impairment of glycosaminoglycan synthesis in mucopolysaccharidosis type IIIA cells by using siRNA: a potential therapeutic approach for Sanfilippo disease
- (2009) Dariusz Dziedzic et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses
- (2009) Roberto Calcedo et al. JOURNAL OF INFECTIOUS DISEASES
- Guidelines for the Management of Mucopolysaccharidosis Type I
- (2009) Ana Maria Martins et al. JOURNAL OF PEDIATRICS
- Involvement of the Toll-like receptor 4 pathway and use of TNF- antagonists for treatment of the mucopolysaccharidoses
- (2009) C. M. Simonaro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reprogramming erythroid cells for lysosomal enzyme production leads to visceral and CNS cross-correction in mice with Hurler syndrome
- (2009) D. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Correlation between severity of mucopolysaccharidoses and combination of the residual enzyme activity and efficiency of glycosaminoglycan synthesis
- (2008) Ewa Piotrowska et al. ACTA PAEDIATRICA
- Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase
- (2008) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice
- (2008) Adriana M. Montaño et al. MOLECULAR GENETICS AND METABOLISM
- The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
- (2008) David Moore et al. Orphanet Journal of Rare Diseases
- Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I
- (2008) L. A. Clarke et al. PEDIATRICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now